News | March 17, 2024
Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
Both organisations enter into a long- term collaboration to expand patient access in India
Both organisations enter into a long- term collaboration to expand patient access in India
Vision loss due to Glaucoma can be prevented if it is detected and treated early
These approvals mark significant progress for Venus Remedies in expanding its market presence
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
BHL will undertake the development and supply of these molecules
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
iSolveSM information on demand is the result of our focus on customer relationship
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
Subscribe To Our Newsletter & Stay Updated
